ArticleMikrochimica acta2025
MIL-125@ZIF-8 based solid phase microextraction coating for sensitive determination of organophosphate esters in aqueous environments.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
A novel MOF-on-MOF heterostructure (MIL-125@ZIF-8) was synthesized and utilized as a coating material for solid-phase microextraction (SPME), which was subsequently coupled with gas chromatography (GC) for the sensitive determination of organophosphate esters (OPEs) in water samples. Compared to commercial fiber, the MIL-125@ZIF-8 coated fiber (MIL-125@ZIF-8-F) demonstrated superior extraction performance for medium-polar or non-polar compounds due to multiple interactions such as hydrophobic interaction, π-π stacking, and hydrogen bonding. The synergistic effect of MIL-125 and ZIF-8 endowed the MIL-125@ZIF-8-F with high efficiency and excellent stability under extreme conditions. Specifically, the developed MIL-125@ZIF-8-F could withstand 80 conditioning cycles without significant loss of extraction capacity. Moreover, the established method exhibited a wide linear range (10-1000 μg L
Indexed as
Identifiers
40153057What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.